文献速递冠心病

ESC 0/1小时算法(高敏肌钙蛋白T)在不同年龄组中的表现

European Society of Cardiology 0/1-hour algorithm (high-sensitivity cardiac troponin T) performance across distinct age groups.
PubMed 文献 · Heart · 2024-05-23

本研究为美国8个中心的前瞻性急诊胸痛患者亚组分析,按年龄分为老年、中年和年轻组,评估ESC 0/1-h hs-cTnT算法对30天心源性死亡或心梗的阴性预测值。结果显示老年和中年组NPV未达99%安全阈值,联合HEART评分后老年组NPV升至100%。

要点

  • ESC 0/1-h算法在年轻组NPV达99.4%,安全可行。
  • 老年组NPV仅97.1%,未达99%安全阈值。
  • 联合HEART评分可提高老年组NPV至100%。

核心结论

  • 在老年和中年成人中,hs-cTnT ESC 0/1-h算法未能达到30天心源性死亡或心梗的99% NPV,除非联合HEART评分。

研究设计与样本

  • 前瞻性队列的亚组分析,纳入美国8个中心急诊胸痛成人患者,按年龄分层为老年(≥65岁)、中年(46-64岁)和年轻(21-45岁)。

主要发现

  • 30天心源性死亡或心梗总发生率为12.8%(183/1430)。
  • ESC 0/1-h算法排除比例:老年组35.6%(137/385),中年组62.1%(510/821),年轻组79.9%(179/224),p<0.001。
  • 30天心源性死亡或心梗NPV:老年组97.1%(95%CI 92.7% to 99.2%),中年组98.4%(95%CI 96.9% to 99.3%),年轻组99.4%(95%CI 96.9% to 100%)。
  • 联合HEART评分后NPV:老年组100%(95%CI 87.7% to 100%),中年组99.2%(95%CI 97.2% to 99.9%),年轻组99.4%(95%CI 96.6% to 100%)。

关键数值与推荐

  • ESC 0/1-h算法使用hs-cTnT(Roche Diagnostics)0小时和1小时测量值。
  • NPV安全阈值为≥99%用于30天心源性死亡或心梗。
  • HEART评分包括病史、心电图、年龄、危险因素和肌钙蛋白。

临床怎么用

  • 对年轻急诊胸痛患者,可单独使用ESC 0/1-h hs-cTnT算法安全排除。
  • 对老年和中年患者,建议联合HEART评分以提高NPV至安全阈值。

局限性

  • 本研究为亚组分析,结果需在更广泛人群中验证。
  • HEART评分联合后老年组NPV的95%CI较宽(87.7% to 100%),存在不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To determine if the European Society of Cardiology 0/1-hour (ESC 0/1-h) algorithm with high-sensitivity cardiac troponin T (hs-cTnT) meets the ≥99% negative predictive value (NPV) safety threshold for 30-day cardiac death or myocardial infarction (MI) in older, middle-aged and young subgroups. METHODS: We conducted a subgroup analysis of adult emergency department patients with chest pain prospectively enrolled from eight US sites (January 2017 to September 2018). Patients were stratified into rule-out, observation and rule-in zones using the hs-cTnT ESC 0/1-h algorithm and classified as older (≥65 years), middle aged (46-64 years) or young (21-45 years). Patients had 0-hour and 1-hour hs-cTnT measures (Roche Diagnostics) and a History, ECG, Age, Risk factor and Troponin (HEART) score. Fisher's exact tests compared rule-out and 30-day cardiac death or MI rates between ages. NPVs with 95% CIs were calculated for the ESC 0/1-h algorithm with and without the HEART score. RESULTS: Of 1430 participants, 26.9% (385/1430) were older, 57.4% (821/1430) middle aged and 15.7% (224/1430) young. Cardiac death or MI at 30 days occurred in 12.8% (183/1430). ESC 0/1-h algorithm ruled out 35.6% (137/385) of older, 62.1% (510/821) of middle-aged and 79.9% of (179/224) young patients (p<0.001). NPV for 30-day cardiac death or MI was 97.1% (95% CI 92.7% to 99.2%) among older patients, 98.4% (95% CI 96.9% to 99.3%) in middle-aged patients and 99.4% (95% CI 96.9% to 100%) among young patients. Adding a HEART score increased NPV to 100% (95% CI 87.7% to 100%) for older, 99.2% (95% CI 97.2% to 99.9%) for middle-aged and 99.4% (95% CI 96.6% to 100%) for young patients. CONCLUSIONS: In older and middle-aged adults, the hs-cTnT ESC 0/1-h algorithm was unable to reach a 99% NPV for 30-day cardiac death or MI unless combined with a HEART score. TRIAL REGISTRATION NUMBER: NCT02984436.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Millard, Ashburn, Snavely, et al. European Society of Cardiology 0/1-hour algorithm (high-sensitivity cardiac troponin T) performance across distinct age groups. Heart. 2024. PMID: 38471727. doi:10.1136/heartjnl-2023-323621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。